The higher vulnerability of this subtype compared to HPV-associated HNSCC is likely because of the aforementioned CCND1 amplification and p16INK4A inactivation by gene deletion, point mutation, or transcriptional silencing via methylation [20]. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.